Business Description

TrivarX Ltd
NAICS : 541711
ISIN : AU0000300196
Description
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 53 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -16.56 | |||||
Beneish M-Score | -4.06 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45 | |||||
3-Year EPS without NRI Growth Rate | 49 | |||||
3-Year FCF Growth Rate | 46.3 | |||||
3-Year Book Growth Rate | -50.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.9 | |||||
9-Day RSI | 38.46 | |||||
14-Day RSI | 42.92 | |||||
3-1 Month Momentum % | 26.67 | |||||
6-1 Month Momentum % | -13.64 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.78 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.8 | |||||
Shareholder Yield % | -63.33 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -12409.09 | |||||
Net Margin % | -14181.82 | |||||
ROE % | -17.47 | |||||
ROA % | -15.1 | |||||
ROIC % | -25.06 | |||||
3-Year ROIIC % | -32.13 | |||||
ROC (Joel Greenblatt) % | -2350.55 | |||||
ROCE % | -17.36 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.67 | |||||
EV-to-EBIT | -4.65 | |||||
EV-to-EBITDA | -4.98 | |||||
EV-to-FCF | -1.67 | |||||
Earnings Yield (Greenblatt) % | -21.51 | |||||
FCF Yield % | -53.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TrivarX Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.005 | ||
Beta | 1.05 | ||
3-Year Sharpe Ratio | -0.1 | ||
3-Year Sortino Ratio | -0.15 | ||
Volatility % | 42.83 | ||
14-Day RSI | 42.92 | ||
14-Day ATR (A$) | 0.001118 | ||
20-Day SMA (A$) | 0.0177 | ||
12-1 Month Momentum % | -50 | ||
52-Week Range (A$) | 0.014 - 0.045 | ||
Shares Outstanding (Mil) | 466.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TrivarX Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TrivarX Ltd Stock Events
Event | Date | Price (A$) | ||
---|---|---|---|---|
No Event Data |
TrivarX Ltd Frequently Asked Questions
What is TrivarX Ltd(ASX:TRI)'s stock price today?
The current price of ASX:TRI is A$0.02. The 52 week high of ASX:TRI is A$0.05 and 52 week low is A$0.01.
When is next earnings date of TrivarX Ltd(ASX:TRI)?
The next earnings date of TrivarX Ltd(ASX:TRI) is 2025-08-28 Est..
Does TrivarX Ltd(ASX:TRI) pay dividends? If so, how much?
TrivarX Ltd(ASX:TRI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |